Long-term episodic memory decline is associated with olfactory deficits only in carriers of ApoE-ε4

Neuropsychologia

Volumn 85, Issue , 2016, Pages 1-9

  Olofsson, Jonas K ^a,b   Josefsson, Maria ^c   Ekström, Ingrid ^a   Wilson, Donald ^d   Nyberg, Lars ^c   Nordin, Steven ^c   Nordin Adolfsson, Annelie ^c   Adolfsson, Rolf ^c   Nilsson, Lars Göran ^a   Larsson, Maria ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b Swedish Collegium for Advanced Study   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Alzheimer disease; Dementia; Memory; Mild cognitive impairment; Olfactory perception

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4; FRAGRANCE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; ODOR RECOGNITION TEST; SMELLING DISORDER; AGING; ANALYSIS OF VARIANCE; COMPLICATION; GENETICS; LEARNING; MEMORY DISORDER; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; COHORT STUDIES; DISCRIMINATION (PSYCHOLOGY); FEMALE; HUMANS; MALE; MEMORY DISORDERS; MEMORY, EPISODIC; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODORANTS; OLFACTION DISORDERS; VERBAL LEARNING;

EID: 84960331151     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2016.03.004     Document Type: Article

References (82)

1. Agosta F., Vossel K.A., Miller B.L., Migliaccio R., Bonasera S.J., Filippi M., Boxer A.L., Karydas A., Possin K.L., Gorno-Tempini M.L. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc. Natl. Acad. Sci. USA 2009, 106(6):2018-2022. 10.1073/pnas.0812697106.
2. Albers M.W., Tabert M.H., Devanand D.P. Olfactory dysfunction as a predictor of neurodegenerative disease. Curr. Neurol. Neurosci. Rep. 2006, 6(5):379-386. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/16928347.
3. American Psychological Association, A., 2000. Diagnostic and Statistical Manual of Mental Disorders, fourth ed., Washington, DC.
4. Arshamian A., Iannilli E., Gerber J.C., Willander J., Persson J., Seo H.S., Hummel T., Larsson M. The functional neuroanatomy of odor evoked autobiographical memories cued by odors and words. Neuropsychologia 2013, 51(1):123-131. 10.1016/j.neuropsychologia.2012.10.023.
5. Attems J., Lintner F., Jellinger K.A. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J. Alzheimers Dis. 2005, 7(2):149-157. discussion 173-180. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/15851853.
6. Attems J., Walker L., Jellinger K.A. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol. 2014, 127(4):459-475. 10.1007/s00401-014-1261-7.
7. Bacon A.W., Bondi M.W., Salmon D.P., Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease and the role of Apolipoprotein E in olfaction. Ann. N.Y. Acad. Sci. 1998, 855:723-731. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/9929677.
8. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9(10):768-778. 10.1038/nrn2494.
9. Brettschneider J., Del Tredici K., Lee V.M., Trojanowski J.Q. Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat. Rev. Neurosci. 2015, 16(2):109-120. 10.1038/nrn3887.
10. Calhoun-Haney R., Murphy C. Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or dementia rating scale scores. Brain Cogn. 2005, 58(2):178-182. 10.1016/j.bandc.2004.10.004.
11. Carmichael S.T., Clugnet M.C., Price J.L. Central olfactory connections in the macaque monkey. J. Comp. Neurol. 1994, 346(3):403-434. 10.1002/cne.903460306.
12. Conti M.Z., Vicini-Chilovi B., Riva M., Zanetti M., Liberini P., Padovani A., Rozzini L. Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. Arch. Clin. Neuropsychol. 2013, 28(5):391-399. 10.1093/arclin/act032.
13. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Hanes J.L., Pericak-Vance M.A. Gene dose of Apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123):921-923. (Retrieved from) 〈http://www.ncbi.nlm.nih.gov/pubmed/8346443〉.
14. Davies G., Armstrong N., Bis J.C., Bressler J., Chouddaki V., Giddaluru S., Deary I.J. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium. Mol. Psychiatry 2015, 20(2):183-192.
15. Del Tredici K., Braak H. Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign: commentary on "no disease in the brain of a 115-year-old woman. Neurobiol. Aging 2008, 29(8):1133-1136. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/18584785.
16. Devanand D.P., Lee S., Manly J., Andrews H., Schupf N., Doty R.L., Stern Y., Zahodne L.B., Louis E.D., Mayeux R. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology 2015, 84(2):182-189. 10.1212/WNL.0000000000001132.
17. Devanand D.P., Liu X., Tabert M.H., Pradhaban G., Cuasay K., Bell K., de Leon M.J., Doty R.L., Stern Y., Pelton G.H. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol. Psychiatry 2008, 64(10):871-879. 10.1016/j.biopsych.2008.06.020.
18. Devanand D.P., Michaels-Marston K.S., Liu X., Pelton G.H., Padilla M., Marder K., Bell K., Stern Y., Mayeux R. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am. J. Psychiatry 2000, 157(9):1399-1405. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/10964854.
19. Djordjevic J., Jones-Gotman M., De Sousa K., Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2008, 29(5):693-706. 10.1016/j.neurobiolaging.2006.11.014.
20. Dong J., Yang J., Tranah G., Franceschini N., Parimi N., Alkorta-Aranburu G., Xu Z., Alonso A., Cummings S.R., Fornage M., Huang X., Kritchevsky S., Liu Y., London S., Niu L., Wilson R.S., De Jager P.L., Yu L., Singleton A.B., Harris T., Mosley T.H., Pinto J.M., Bennett D.A., Chen H. Genome-wide meta-analysis on the sense of smell among US older adults. Medicine 2015, 94(47):e1892. 10.1097/MD.0000000000001892.
21. Doty R.L., Marcus A., Lee W.W. Development of the 12-item cross-cultural smell identification test (CC-SIT. Laryngoscope 1996, 106(3 Pt 1):353-356. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/8614203.
22. Doty R.L., Petersen I., Mensah N., Christensen K. Genetic and environmental influences on odor identification ability in the very old. Psychol. Aging 2011, 26(4):864-871. 10.1037/a0023263.
23. Doty R.L., Shaman P., Applebaum S.L., Giberson R., Siksorski L., Rosenberg L. Smell identification ability: changes with age. Science 1984, 226(4681):1441-1443. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/6505700.
24. Doty R.L., Shaman P., Dann M. Development of the university of Pennsylvania smell identification test: a standardized Microencapsulated test of olfactory function. Physiol. Behav. 1984, 32(3):489-502. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/6463130.
25. Doty R.L., Tourbier I., Ng V., Neff J., Armstrong D., Battistini M., Sammel M.D., Gettes D., Evans D.L., Mirza N., Moberg P.J., Connolly T., Sondheimer S.J. Influences of Hormone replacement therapy on olfactory and cognitive function in postmenopausal women. Neurobiol. Aging 2015, 36(6):2053-2059. 10.1016/j.neurobiolaging.2015.02.028.
26. Dulay M.F., Murphy C. Olfactory acuity and cognitive function converge in older adulthood: support for the common cause hypothesis. Psychol. Aging 2002, 17(3):392-404. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/12243381.
27. Dureman I., Kebbon L., Österberg E. Manual till DS-Batteriet. (Manual for the DS Battery) 1971, Psykologiförlaget, Stockholm.
28. Eichenbaum H. A cortical-hippocampal system for declarative memory. Nat. Rev. Neurosci. 2000, 1(1):41-50. 10.1038/35036213.
29. Finkel D., Pedersen N.L., Larsson M. Olfactory functioning and cognitive abilities: a twin study. J. Gerontol. B Psychol. Sci. Soc. Sci. 2001, 56(4):P226-233. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/11445609.
30. Finkel D., Reynolds C.A., Larsson M., Gatz M., Pedersen N.L. Both odor identification and ApoE-epsilon4 contribute to normative cognitive aging. Psychol. Aging 2011, 26(4):872-883. 10.1037/a0023371.
31. Gorelick P.B., Scuteri A., Black S.E., Decarli C., Greenberg S.M., Iadecola C., Launer L.J., Laurent S., Lopez O.L., Nyenhuis D., Petersen R.C., Schneider J.A., Tzourio C., Arnett D.K., Bennett D.A., Chui H.C., Higashida R.T., Lindquist R., Nilsson P.M., Roman G.C., Sellke F.W., Seshadri S., American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Surgery and Anesthesia Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42(9):2672-2713. 10.1161/STR.0b013e3182299496.
32. Graves A.B., Bowen J.D., Rajaram L., McCormick W.C., McCurry S.M., Schellenberg G.D., Larson E.B. Impaired olfaction as a marker for cognitive decline: interaction with Apolipoprotein E epsilon4 status. Neurology 1999, 53(7):1480-1487. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/10534255.
33. Hashimoto M., Yasuda M., Tanimukai S., Matsui M., Hirono N., Kazui H., Mori E. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 2001, 57(8):1461-1466. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/11673590.
34. Herz R.S., Eliassen J., Beland S., Souza T. Neuroimaging evidence for the emotional potency of odor-evoked memory. Neuropsychologia 2004, 42(3):371-378. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/14670575.
35. Hummel T., Kobal G., Gudziol H., Mackay-Sim A. Normative data for the "Sniffin' Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3000 subjects. Eur. Arch. Otorhinolaryngol. 2007, 264(3):237-243. 10.1007/s00405-006-0173-0.
36. Josefsson M., de Luna X., Pudas S., Nilsson L.G., Nyberg L. Genetic and lifestyle predictors of 15-year longitudinal change in episodic memory. J. Am. Geriatr. Soc. 2012, 60(12):2308-2312. 10.1111/jgs.12000.
37. Kjelvik G., Evensmoen H.R., Brezova V., Haberg A.K. The human brain representation of odor identification. J. Neurophysiol. 2012, 108(2):645-657. 10.1152/jn.01036.2010.
38. Kjelvik G., Saltvedt I., White L.R., Stenumgard P., Sletvold O., Engedal K., Skatum K., Lyngvær A.K., Steffenach H.A., Haberg A.K. The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease. BMC Neurol. 2014, 14:168. 10.1186/s12883-014-0168-1.
39. Kunz L., Schroder T.N., Lee H., Montag C., Lachmann B., Sariyska R., Reuter M., Stirnberg R., Messing-Floeter P.C., Fell J., Doeller C.F., Axmacher N. Reduced grid-cell-like representations in adults at genetic risk for Alzheimer's disease. Science 2015, 350(6259):430-433. 10.1126/science.aac8128.
40. Larsson M., Hedner M., Papenberg G., Seubert J., Bäckman L., Laukka E.J. Olfactory memory in the old and very old: relations to episodic and semantic memory and APOE genotype. Neurobiol. Aging 2016, 38:118-126.
41. Larsson M., Nilsson L.G., Olofsson J.K., Nordin S. Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. Chem. Senses 2004, 29(6):547-554. 10.1093/chemse/bjh059.
42. Lind J., Larsson A., Persson J., Ingvar M., Nilsson L.G., Backman L., Adolfsson R., Cruts M., Sleegers K., Van Broeckhoven C., Nyberg L. Reduced hippocampal volume in non-demented carriers of the Apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci. Lett. 2006, 396(1):23-27. 10.1016/j.neulet.2005.11.070.
43. Lipnicki D.M., Sachdev P.S., Crawford J., Reppermund S., Kochan N.A., Trollor J.N., Draper B., Slavin M.J., Kang K., Lux O., Mather K.A., Brodaty H. Risk factors for late-life cognitive decline and variation with age and sex in the Sydney memory and ageing study. PLoS One 2013, 8(6):e65841. 10.1371/journal.pone.0065841.
44. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-alzheimer's association Workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7(3):263-269. 10.1016/j.jalz.2011.03.005.
45. Mesholam R.I., Moberg P.J., Mahr R.N., Doty R.L. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch. Neurol. 1998, 55(1):84-90. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/9443714.
46. Morgan C.D., Murphy C. Olfactory event-related potentials in Alzheimer's disease. J. Int. Neuropsychol. Soc. 2002, 8(6):753-763. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/12240739.
47. Murphy C., Gilmore M.M., Seery C.S., Salmon D.P., Lasker B.R. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol. Aging 1990, 11(4):465-469. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/2381506.
48. Murphy C., Jernigan T.L., Fennema-Notestine C. Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study. J. Int. Neuropsychol. Soc. 2003, 9(3):459-471. 10.1017/S1355617703930116.
49. Nilsson L.G., Adolfsson R., Backman L., de Frias C.M., Molander B., Nyberg L. Betula: a prospective cohort study on memory, health and aging. Aging Neuropsychol. Cogn. 2004, 11.
50. Nilsson L.G., Backman L., Erngrund K., Nyberg L., Adolfsson R., Bucht G., Winblad B. The Betula Prospektive cohort study: memory, health and aging. Aging Neuropsychol. Cogn. 1997, 4(1):1-32.
51. Nordin S., Bramerson A., Liden E., Bende M. The Scandinavian odor-identification test: development, reliability, validity and normative data. Acta Otolaryngol. 1998, 118(2):226-234. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/9583791.
52. Nyberg L., Lovden M., Riklund K., Lindenberger U., Backman L. Memory aging and brain maintenance. Trends Cogn. Sci. 2012, 16(5):292-305. 10.1016/j.tics.2012.04.005.
53. Olofsson J.K., Bowman N.E., Khatibi K., Gottfried J.A. A time-based account of the perception of odor objects and valences. Psychol. Sci. 2012, 23(10):1224-1232. 10.1177/0956797612441951.
54. Olofsson J.K., Gottfried J.A. The muted sense: neurocognitive limitations of olfactory language. Trends Cogn. Sci. 2015, 19(6):314-321. 10.1016/j.tics.2015.04.007.
55. Olofsson J.K., Hurley R.S., Bowman N.E., Bao X., Mesulam M.M., Gottfried J.A. A designated odor-language integration system in the human brain. J. Neurosci. 2014, 34(45):14864-14873. 10.1523/JNEUROSCI.2247-14.2014.
56. Olofsson J.K., Nordin S., Wiens S., Hedner M., Nilsson L.G., Larsson M. Odor identification impairment in carriers of ApoE-varepsilon4 is independent of clinical dementia. Neurobiol. Aging 2010, 31(4):567-577. 10.1016/j.neurobiolaging.2008.05.019.
57. Olofsson J.K., Rogalski E., Harrison T., Mesulam M.M., Gottfried J.A. A cortical pathway to olfactory naming: evidence from primary progressive aphasia. Brain 2013, 136(Pt 4):1245-1259. 10.1093/brain/awt019.
58. Olofsson J.K., Ronnlund M., Nordin S., Nyberg L., Nilsson L.G., Larsson M. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4. Behav. Genet. 2009, 39(5):496-503. 10.1007/s10519-009-9289-5.
59. Parola S., Liberini P. Assessing olfaction in the Italian population: methodology and clinical application. Ital. J. Neurol. Sci. 1999, 20(5):287-296. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/10933437.
60. Persson J., Nyberg L., Lind J., Larsson A., Nilsson L.G., Ingvar M., Buckner R.L. Structure-function correlates of cognitive decline in aging. Cereb. Cortex 2006, 16(7):907-915. 10.1093/cercor/bhj036.
61. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56(3):303-308. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/10190820.
62. Pievani M., Rasser P.E., Galluzzi S., Benussi L., Ghidoni R., Sabattoli F., Bonetti M., Binetti G., Thompson P.M., Frisoni G.B. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo. Neuroimage 2009, 45(4):1090-1098. 10.1016/j.neuroimage.2009.01.009.
63. Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of Tangles, Plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 1991, 12(4):295-312. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/1961359.
64. Reyes P.F., Deems D.A., Suarez M.G. Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study. Brain Res. Bull. 1993, 32(1):1-5. (Retrived from). http://www.ncbi.nlm.nih.gov/pubmed/8319097.
65. Roberts R.O., Christianson T.J., Kremers W.K., Mielke M.M., Machulda M.M., Vassilaki M., Petersen R.C. Association between olfactory dysfunction and Amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurol. 2015, 1-9. 10.1001/jamaneurol.2015.2952.
66. Royall D.R., Chiodo L.K., Polk M.S., Jaramillo C.J. Severe Dysosmia is specifically associated with alzheimer-like memory deficits in Nondemented elderly retirees. Neuroepidemiology 2002, 21(2):68-73. doi: 48619.
67. Schubert C.R., Carmichael L.L., Murphy C., Klein B.E., Klein R., Cruickshanks K.J. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of Older adults. J. Am. Geriatr. Soc. 2008, 56(8):1517-1521. 10.1111/j.1532-5415.2008.01826.x.
68. Segura B., Baggio H.C., Solana E., Palacios E.M., Vendrell P., Bargallo N., Junque C. Neuroanatomical correlates of olfactory loss in normal aged subjects. Behav. Brain Res. 2013, 246:148-153. 10.1016/j.bbr.2013.02.025.
69. Small B.J., Rosnick C.B., Fratiglioni L., Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol. Aging 2004, 19(4):592-600. 10.1037/0882-7974.19.4.592.
70. Smith G.E., Bohac D.L., Waring S.C., Kokmen E., Tangalos E.G., Ivnik R.J., Petersen R.C. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998, 50(2):355-362. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/9484353.
71. Sohrabi H.R., Bates K.A., Weinborn M.G., Johnston A.N., Bahramian A., Taddei K., Laws S.M., Rodrigues M., Morici M., Howard M., Martins G., Mackay-Sim A., Gandy S.E., Martins R.N. Olfactory discrimination predicts cognitive decline among community-dwelling Older adults. Transl. Psychiatry 2012, 2:e118. 10.1038/tp.2012.43.
72. Stanciu I., Larsson M., Nordin S., Adolfsson R., Nilsson L.G., Olofsson J.K. Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: a longitudinal, population-based study. J. Int. Neuropsychol. Soc. 2014, 20(2):209-217. 10.1017/S1355617713001409.
73. Swan G.E., Carmelli D. Impaired olfaction predicts cognitive decline in Nondemented Older adults. Neuroepidemiology 2002, 21(2):58-67. doi:48618.
74. Tabert M.H., Liu X., Doty R.L., Serby M., Zamora D., Pelton G.H., Marder K., Albers M.W., Stern Y., Devanand D.P. A 10-item smell identification scale related to risk for Alzheimer's disease. Ann. Neurol. 2005, 58(1):155-160. 10.1002/ana.20533.
75. Vargha-Khadem F., Gadian D.G., Watkins K.E., Connelly A., Van Paesschen W., Mishkin M. Differential effects of early Hippocampal pathology on episodic and semantic memory. Science 1997, 277(5324):376-380. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/9219696.
76. Wenham P.R., Price W.H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991, 337(8750):1158-1159. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/1674030.
77. Wesson D.W., Wilson D.A., Nixon R.A. Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?. Expert Rev. Neurother. 2010, 10(5):633-635. 10.1586/ern.10.33.
78. Willander J., Larsson M. Smell your way back to childhood: autobiographical odor memory. Psychon. Bull. Rev. 2006, 13(2):240-244. (Retrieved from). http://www.ncbi.nlm.nih.gov/pubmed/16892988.
79. Wilson R.S., Arnold S.E., Schneider J.A., Tang Y., Bennett D.A. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J. Neurol. Neurosurg. Psychiatry 2007, 78(1):30-35. 10.1136/jnnp.2006.099721.
80. Wilson R.S., Arnold S.E., Tang Y., Bennett D.A. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology 2006, 26(2):61-67. 10.1159/000090250.
81. Wilson R.S., Schneider J.A., Arnold S.E., Tang Y., Boyle P.A., Bennett D.A. Olfactory identification and incidence of mild cognitive impairment in older age. Arch. Gen. Psychiatry 2007, 64(7):802-808. 10.1001/archpsyc.64.7.802.
82. Wolk D.A., Dickerson B.C., Alzheimer's Disease Neuroimaging I. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2010, 107(22):10256-10261. 10.1073/pnas.1001412107.